Filtros : "Indexado no Index Medicus" "gu" Removidos: "GEOGRAFIA" "Dimas, Antônio" "Oliveira, Ariovaldo Umbelino de" "ARBIX, GLAUCO ANTONIO TRUZZI" "Financiado pela FDTE/CeleoRedes" "Indexado no: MEDLINE" "Elias Jr., Jorge" Limpar

Filtros



Refine with date range


  • Source: Electrophoresis. Unidade: FCFRP

    Subjects: FÁRMACOS, QUÍMICA ANALÍTICA

    Acesso à fonteDOIHow to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
    • ABNT

      BORGES, Keyller Bastos et al. Box-behnken design for te optimization of an enantioselective method for the simultaneous analysis of propranolol and 4-hydroxypropranolol by CE. Electrophoresis, v. 30, n. 16, p. 2874-2881, 2009Tradução . . Disponível em: https://doi.org/10.1002/elps.200800821. Acesso em: 03 jul. 2024.
    • APA

      Borges, K. B., Pupo, M. T., Freitas, L. A. P. de, & Bonato, P. S. (2009). Box-behnken design for te optimization of an enantioselective method for the simultaneous analysis of propranolol and 4-hydroxypropranolol by CE. Electrophoresis, 30( 16), 2874-2881. doi:10.1002/elps.200800821
    • NLM

      Borges KB, Pupo MT, Freitas LAP de, Bonato PS. Box-behnken design for te optimization of an enantioselective method for the simultaneous analysis of propranolol and 4-hydroxypropranolol by CE [Internet]. Electrophoresis. 2009 ; 30( 16): 2874-2881.[citado 2024 jul. 03 ] Available from: https://doi.org/10.1002/elps.200800821
    • Vancouver

      Borges KB, Pupo MT, Freitas LAP de, Bonato PS. Box-behnken design for te optimization of an enantioselective method for the simultaneous analysis of propranolol and 4-hydroxypropranolol by CE [Internet]. Electrophoresis. 2009 ; 30( 16): 2874-2881.[citado 2024 jul. 03 ] Available from: https://doi.org/10.1002/elps.200800821
  • Source: Thrombosis and Haemostasis. Unidade: FMRP

    Subjects: GENÉTICA MÉDICA, MUTAGÊNESE, HEMATOLOGIA

    How to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
    • ABNT

      FRANCO, R F et al. The prevalence of factor V 'Arg POT.306''seta'Thr (factor V Cambridge) and factor V 'Arg POT.306''seta' Gly mutations in different human populations. [Carta]. Thrombosis and Haemostasis. Stuttgart: Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo. . Acesso em: 03 jul. 2024. , 1999
    • APA

      Franco, R. F., Elion, J., Tavella, M. H., Santos, S. E. B., & Zago, M. A. (1999). The prevalence of factor V 'Arg POT.306''seta'Thr (factor V Cambridge) and factor V 'Arg POT.306''seta' Gly mutations in different human populations. [Carta]. Thrombosis and Haemostasis. Stuttgart: Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo.
    • NLM

      Franco RF, Elion J, Tavella MH, Santos SEB, Zago MA. The prevalence of factor V 'Arg POT.306''seta'Thr (factor V Cambridge) and factor V 'Arg POT.306''seta' Gly mutations in different human populations. [Carta]. Thrombosis and Haemostasis. 1999 ; 81 312-313.[citado 2024 jul. 03 ]
    • Vancouver

      Franco RF, Elion J, Tavella MH, Santos SEB, Zago MA. The prevalence of factor V 'Arg POT.306''seta'Thr (factor V Cambridge) and factor V 'Arg POT.306''seta' Gly mutations in different human populations. [Carta]. Thrombosis and Haemostasis. 1999 ; 81 312-313.[citado 2024 jul. 03 ]

Digital Library of Intellectual Production of Universidade de São Paulo     2012 - 2024